Dysregulations of functional RNA modifications and hexavalent chromium lung carcinogenesis
功能性RNA修饰失调与六价铬肺癌发生
基本信息
- 批准号:10381280
- 负责人:
- 金额:$ 41.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-08 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AffectBiological AssayBiological ProcessBiologyCISH geneCancer EtiologyCarcinogensCellsChemicalsChronicControl GroupsCountryDNADataDown-RegulationEnvironmental CarcinogensEnvironmental HealthEnzyme-Linked Immunosorbent AssayExposure toGene ExpressionGoalsHistonesHumanImpairmentIncidenceJanus kinaseLungLung NeoplasmsLysineMalignant neoplasm of lungMediatingMessenger RNAMetal CarcinogenesisMethyltransferaseMicroarray AnalysisModificationMonoubiquitinationMusNucleotidesOccupationalOncogenicPathway interactionsPersonsPlayPost-Translational Protein ProcessingProcessPromoter RegionsPropertyProteinsRNARNA Polymerase IIRNA StabilityReaderResistanceReview LiteratureRiboseRoleSTAT proteinSmall Interfering RNATumor BurdenTumor TissueTumorigenicityUnited StatesUntranslated RNAUp-RegulationWestern Blottingbasecancer stem cellcancer therapycarcinogenesiscarcinogenicitycell transformationchromium hexavalent ionconditional knockoutenvironmental carcinogenesisinsightknock-downlung carcinogenesislung tumorigenesismouse modelnoveloverexpressionpollutantpromoterrecruitstem cell self renewalstem-like celltranscriptome sequencingtumor progressiontumorigenesisubiquitin-protein ligase
项目摘要
PROJECT SUMMARY/ABSTRACT
Hexavalent chromium [Cr(VI)] is one of the most common environmental carcinogens causing lung cancer,
however, the mechanism of Cr(VI) carcinogenesis remains elusive. The N6-methyladenosine (m6A) modification is
the most prevalent internal modification in eukaryotic messenger RNAs (mRNAs), which is dynamically regulated
by three groups of proteins known as writers, erasers and readers. Recent advances in demonstrating the vital
roles of RNA m6A modifications in regulating gene expression and a variety of biological processes represents a
breakthrough in understanding RNA biology and functions. Moreover, accumulating evidence has shown that up-
regulation of m6A modifications plays critical roles in cancer progression and cancer therapy resistances. However,
it remains largely un-explored whether the m6A modification dysregulation plays a role in the carcinogenic process
especially in environmental carcinogenesis. The goal of this study is to investigate the mechanism of Cr(VI)
carcinogenesis by studying RNA m6A modification dysregulations, focusing on the role and mechanism of chronic
Cr(VI) exposure-caused m6A writer methyltransferase like 3 (METTL3) up-regulation. Our preliminary studies found:
(i) Chronic Cr(VI) exposure up-regulates METTL3 expression, which contributes causally to Cr(VI)-induced cell
transformation, CSC-like property and tumorigenesis. (ii) METTL3 up-regulation is also similarly detected in chronic
Cr(VI) exposure-caused human and mouse lung tumor tissues. (iii) The Jak2-Stat3 pathway is activated. (iv) Jak2
and SOCS3 mRNA levels are increased and decreased in Cr(VI)-transformed cells, respectively. Stably knocking
down METTL3 significantly decreases Jak2 but increases SOCS3 mRNA levels. (v) Inhibition of the Jak2-Stat3
oncogenic pathway in Cr(VI)-transformed cells significantly reduces their CSC-like property. (vi) The repressive
histone 2A (H2A) lysine 119 (K119) monoubiquitination (H2AK119ub1) levels and H2AK119ub1 enrichment at
METTL3 promoter region are greatly reduced in Cr(VI)-transformed cells. (vii) The expression level of a H2A
deubiquitinase USP28 is up-regulated in Cr(VI)-transformed cells. Knockdown of USP28 increases H2AK119ub1
levels but reduces METTL3 protein levels. Based on literature review and our novel preliminary data, our central
hypothesis is: “METTL3 up-regulation increases Jak2 and SOCS3 mRNA m6A modifications to up-regulate Jak2
but down-regulate SOCS3 expressions, which activates the oncogenic Jak2-Stat3 pathway promoting Cr(VI)
carcinogenesis”. Three aims are proposed: Aim 1 will determine the mechanism of how chronic Cr(VI) exposure up-
regulates METTL3 expression focusing on the role of USP28-mediated down-regulation of histone 2A
monoubiquitination. Aim 2 will demonstrate that METTL3 up-regulation increases Jak2 and SCOS3 mRNA m6A
modifications to activate the Jak2-Stat3 pathway promoting Cr(VI)-exposure-induced CSC-like property and
tumorigenesis. Aim 3 will demonstrate that METTL3 lung-specific deletion using a METTL3 conditional knockout
mouse model impairs Cr(VI) lung tumorigenesis in mice.
项目摘要/摘要
六价铬[CR(VI)]是最常见的环境致癌物之一,导致肺癌,
但是,CR(VI)癌变的机制仍然难以捉摸。 N6-甲基丹代氨酸(M6A)的修饰为
真核信使RNA(mRNA)中最普遍的内部修饰,该修饰是动态调节的
由三组被称为作家,橡皮擦和读者的蛋白质。展示至关重要的最新进展
RNA M6A修饰在调节基因表达和多种生物过程中的作用代表
理解RNA生物学和功能的突破。此外,积累的证据表明,
M6A修饰的调节在癌症进展和癌症耐药性中起关键作用。然而,
M6A修饰失调是否在致癌过程中起作用,在很大程度上没有探索
特别是在环境癌变中。这项研究的目的是研究CR(VI)的机制
通过研究RNA M6A修饰失调,重点关注慢性的作用和机制,致癌
CR(VI)暴露引起的M6A作者甲基转移酶,例如3(METTL3)上调。我们的初步研究发现:
(i)慢性CR(VI)暴露上调METTL3表达,有时会导致CR(VI)诱导的细胞
转化,CSC样性质和肿瘤发生。 (ii)在慢性中也类似地检测到Mettl3上调
CR(VI)暴露引起的人和小鼠肺肿瘤组织。 (iii)激活JAK2-STAT3途径。 (iv)JAK2
SOCS3 mRNA水平分别增加并降低CR(VI)转化的细胞。稳定敲门
下降METTL3显着降低了JAK2,但SOCS3 mRNA水平增加。 (v)抑制JAK2-Stat3
CR(VI)转化细胞中的致癌途径显着降低了其CSC样性质。 (vi)反射性
Hisstone 2A(H2A)赖氨酸119(K119)单次素激(H2AK119UB1)水平和H2AK119UB1富集
在CR(VI)转化的细胞中,METTL3启动子区域大大降低。 (vii)H2a的表达水平
去泛素酶USP28在CR(VI)转化的细胞中被上调。 USP28的敲低增加了H2AK119UB1
水平但降低了Mettl3蛋白水平。根据文献综述和我们的新型初步数据,我们的中央
假设是:“ METTL3上调增加JAK2和SOCS3 mRNA M6A修饰以上调节JAK2
但是下调SOCS3表达式,它激活了促进CR(VI)的致癌JAK2-STAT3途径
提出了三个目标:AIM 1将确定慢性CR(VI)暴露的机制
调节METTL3表达,重点是USP28介导的Hisstone 2a下调的作用
单泛素化。 AIM 2将证明METTL3上调增加JAK2和SCOS3 mRNA M6A
修改以激活JAK2-STAT3途径促进CR(VI)曝光引起的CSC样属性和
肿瘤发生。 AIM 3将证明使用Mettl3有条件敲除的Mettl3肺特异性缺失
小鼠模型会损害小鼠的CR(VI)肺肿瘤发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chengfeng Yang其他文献
Chengfeng Yang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chengfeng Yang', 18)}}的其他基金
Mechanism of Hexavalent Chromium Carcinogenesis Role of Long Non-Coding RNA Dysregulation
六价铬致癌机制与长非编码RNA失调的作用
- 批准号:
10823032 - 财政年份:2023
- 资助金额:
$ 41.58万 - 项目类别:
Dysregulations of functional RNA modifications and hexavalent chromium lungcarcinogenesis
功能性 RNA 修饰失调与六价铬肺癌发生
- 批准号:
10835362 - 财政年份:2023
- 资助金额:
$ 41.58万 - 项目类别:
Dysregulations of functional RNA modifications and hexavalent chromium lung carcinogenesis
功能性RNA修饰失调与六价铬肺癌发生
- 批准号:
10565860 - 财政年份:2022
- 资助金额:
$ 41.58万 - 项目类别:
MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESIS ROLE OF LONG NON-CODING RNA DYSREGULATION
长非编码RNA失调的六价铬致癌机制
- 批准号:
10478174 - 财政年份:2021
- 资助金额:
$ 41.58万 - 项目类别:
MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESIS ROLE OF LONG NON-CODING RNA DYSREGULATION
长非编码RNA失调的六价铬致癌机制
- 批准号:
10372591 - 财政年份:2021
- 资助金额:
$ 41.58万 - 项目类别:
THE EPIGENETIC MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESIS
六价铬致癌的表观遗传机制
- 批准号:
10373379 - 财政年份:2021
- 资助金额:
$ 41.58万 - 项目类别:
Mechanism of hexavalent chromium carcinogenesis - Role of long non-coding RNA dysregulation
六价铬致癌机制——长链非编码RNA失调的作用
- 批准号:
9813295 - 财政年份:2019
- 资助金额:
$ 41.58万 - 项目类别:
The epigenetic mechanism of hexavalent chromium carcinogenesis
六价铬致癌的表观遗传学机制
- 批准号:
9402503 - 财政年份:2016
- 资助金额:
$ 41.58万 - 项目类别:
The epigenetic mechanism of hexavalent chromium carcinogenesis
六价铬致癌的表观遗传学机制
- 批准号:
9326997 - 财政年份:2016
- 资助金额:
$ 41.58万 - 项目类别:
The epigenetic mechanism of hexavalent chromium carcinogenesis
六价铬致癌的表观遗传学机制
- 批准号:
10000927 - 财政年份:2016
- 资助金额:
$ 41.58万 - 项目类别:
相似国自然基金
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:42207312
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
集成微流控芯片应用于高通量精准生物检体测定
- 批准号:
- 批准年份:2020
- 资助金额:60 万元
- 项目类别:面上项目
硫酸盐还原菌生物膜活性的原位快速测定研究
- 批准号:41876101
- 批准年份:2018
- 资助金额:62.0 万元
- 项目类别:面上项目
冬虫夏草抗菌肽的序列测定及其生物学功能研究
- 批准号:81803848
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 41.58万 - 项目类别:
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 41.58万 - 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 41.58万 - 项目类别:
Uncovering the Functional Effects of Neurotrophins in the Auditory Brainstem
揭示神经营养素对听觉脑干的功能影响
- 批准号:
10823506 - 财政年份:2024
- 资助金额:
$ 41.58万 - 项目类别:
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
- 批准号:
10537391 - 财政年份:2023
- 资助金额:
$ 41.58万 - 项目类别: